Identification of a prognostic immune‐related signature for small cell lung cancer

PURPOSE: As a subgroup of lung cancer, small cell lung cancer (SCLC) is characterized by a short tumor doubling time, high rates of early occurred distant cancer spread, and poor outcomes. Despite its exquisite sensitivity to chemotherapy and radiotherapy, acquired drug resistance and tumor progress...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Qi, Chu, Huili, Yi, Jian, Yu, Hui, Gu, Tiantian, Guan, Yaping, Liu, Xiaolin, Liang, Jing, Li, Yan, Wang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Bioinformatics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683526/
https://www.ncbi.nlm.nih.gov/pubmed/34741430
http://dx.doi.org/10.1002/cam4.4402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683526/
https://www.ncbi.nlm.nih.gov/pubmed/34741430
http://dx.doi.org/10.1002/cam4.4402

Ejemplares similares